Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds William Blair Downgrades Actinium Pharmaceuticals to Market Perform

William Blair Downgrades Actinium Pharmaceuticals to Market Perform

William Blair analyst Andy Hsieh downgrades Actinium Pharmaceuticals (AMEX:ATNM) from Outperform to Market Perform.

byBenzinga Newsdesk

February 21, 2023

1 minute read

William Blair analyst Andy Hsieh downgrades Actinium Pharmaceuticals (AMEX:ATNM) from Outperform to Market Perform.

Revlon Obtains Court Approval For $1.4B Bankruptcy Loan: Reuters

By Shivani Kumaresan

August 1, 3:47 PM

Cosmetics company Revlon Inc (NYSE:REV) has received a U.S. bankruptcy judge’s permission to proceed with a $1.4 billion loan, Reuters reported.…

REV

Here’s How Much You Would Have Made Owning Progressive Stock In The Last 20 Years

By Benzinga Insights

August 3, 1:46 PM

Progressive (NYSE:PGR) has outperformed the market over the past 20 years by 3.76% on an annualized basis producing an average annual return of 11.66%. Currently, Progressive has a market capitalization of $66.20 billion.

PGR

News

Cooperative Ventures Announces First Investment In Ag Startup

By Benzinga Newsdesk

November 4, 10:01 AM

Investment in Sabanto designed to help drive turn-key autonomy solutions for farmers and ag retailers while improving sustainability Cooperative Ventures, a venture capital fund formed by North

CHSCP

News

5 Value Stocks To Watch In The Energy Sector

By Benzinga Insights

April 27, 10:39 AM

The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices…

William Blair Downgrades Actinium Pharmaceuticals to Market Perform

Related Posts

Revlon Obtains Court Approval For $1.4B Bankruptcy Loan: Reuters

Here’s How Much You Would Have Made Owning Progressive Stock In The Last 20 Years

Cooperative Ventures Announces First Investment In Ag Startup

5 Value Stocks To Watch In The Energy Sector